DHANUKA AGRITECH LTD.

Dhanuka Agritech Ltd has announced the appointment of Mr. Shalinder Singh as Senior Management Personnel, designated as General Manager- Sales. This appointment is effective from August 3rd, 2026. Mr. Singh brings over 20 years of experience in Sales and Marketing within the Agro-Inputs sector, with a strong background in various geographies and leadership roles at companies like Syngenta and Nagarjuna. He holds a Master of Science in Horticulture from Punjab Agriculture University. This move is expected to bolster the company's sales and marketing strategies.

Dhanuka Agritech Ltd announced its unaudited financial results for the quarter ended June 30, 2026. The Board of Directors also approved an investment of up to ₹200 Crore for a new pesticide manufacturing unit in Nagpur, Maharashtra. Additionally, the company will grant a loan of up to ₹15 Crore to the Dhanuka Employee Stock Benefits Trust for its Stock Appreciation Rights Plan, 2026.

Dhanuka Agritech Ltd's Board of Directors has approved granting a loan of up to ₹15 Crore to the proposed Dhanuka Employee Stock Benefits Trust. This fund will be used for the implementation of the Dhanuka Stock Appreciation Rights Plan, 2026 (SAR 2026). The loan will be disbursed in one or more tranches and is intended for the acquisition of equity shares from the open market and administration of the SAR 2026 plan, in compliance with SEBI regulations. The board meeting also reviewed un-audited financial results for the quarter ended June 30, 2026, and approved an investment of up to ₹200 Crore for a new pesticide manufacturing unit in Nagpur, Maharashtra.

Dhanuka Agritech Ltd announced its Board of Directors has approved an investment of up to ₹200 Crore for establishing a new pesticide manufacturing unit in Nagpur, Maharashtra. The company also approved the un-audited financial results for the quarter ended June 30, 2026, and a loan of up to ₹15 Crore to the Dhanuka Employee Stock Benefits Trust for its "Dhanuka Stock Appreciation Rights Plan, 2026". The board meeting concluded on August 3, 2026.

Dhanuka Agritech opened FY27 with a weak, demand-led print: standalone revenue fell 12.6% YoY to ₹461.9 Cr and net profit dropped 34.6% YoY to ₹36.3 Cr (EPS ₹8.06 vs ₹12.31). This badly misses street and management's own set-up — Uniresearch had pencilled in ₹564 Cr revenue (+6.9%) and ₹64 Cr PAT (+14.3%), and on the Q1 FY26 concall management had guided to low-double-digit FY27 revenue growth on the full-year impact of acquired Bayer products and re-introduced biostimulants. Q1 delivered the opposite of that guidance on the topline, with the agri-input cyclicality management always flags (monsoon, pest, crop patterns) working against it this quarter. The damage is operating deleverage, not a one-off: with no exceptional items on either side, the profit fall is genuine. Net margin compressed to 7.9% from 10.5% a year ago, and EBIT-level margin thinned as expenses (₹422.2 Cr) fell far less than revenue — employee cost (₹46.5 Cr) and other expenses (₹60.9 Cr) were essentially flat YoY against a shrunken topline, while other income of ₹8.9 Cr and lower finance cost cushioned only marginally. The sequential optics are worse still (PAT ₹36.3 Cr vs ₹97.8 Cr in Q4) but that is a seasonality artifact — Q4 is Dhanuka's strong rabi quarter and is not the right comparison; YoY is the clean read here. The board paired the soft result with two capital moves signalling continued confidence in the runway: approval of up to ₹200 Cr for a new 23,000 MT/annum pesticide plant at Nagpur (operational by Mar/Apr 2028, funded by internal accruals/debt) to shorten lead times into South, East and Central India, and a ₹15 Cr loan to the employee trust for the SAR 2026 plan — on top of the ₹70 Cr buyback executed during the quarter. Q2 (kharif) will test whether the guided low-double-digit growth and Bayer/biostimulant contribution actually materialise, or whether the FY27 outlook needs to be reset lower.

Dhanuka Agritech Ltd has issued a clarification regarding the determination of the appreciation amount under its proposed Dhanuka Stock Appreciation Rights Plan, 2026 (SAR 2026). This clarification addresses queries from proxy advisory firms. The appreciation amount for each exercised SAR will be the cash equivalent of the increase in the underlying equity share's value. The calculation is defined as (Fair Market Value on Exercise Date – Exercise Price) × Number of SARs Exercised. The exercise price will be no less than the closing market price on the grant date, considering higher trading volumes on that day. The company has also made this information available on its website.

Dhanuka Agritech Ltd has announced that its Board of Directors will convene on August 3, 2026. The primary agenda for this meeting is to consider and approve the Un-Audited Financial Results for the quarter ended June 30, 2026. The company has also informed that the trading window for designated persons, which was closed from July 1, 2026, will remain closed until 48 hours after the declaration of these financial results.

Dhanuka Agritech Limited has announced its Board of Directors has recommended a final dividend of 100%, amounting to ₹2 per equity share (face value ₹2), for the Financial Year ended March 31, 2026. This recommendation is subject to shareholder approval at the 41st Annual General Meeting scheduled for August 3, 2026. The company also provided details regarding Tax Deducted at Source (TDS) on dividend payments as per the Income Tax Act, 2025. For resident shareholders, TDS is 10% unless PAN is not provided (20%) or if the dividend amount does not exceed ₹10,000 for resident individuals. Shareholders are urged to update their PAN, contact, and bank details with the Registrar and Transfer Agent, M/s. Abhipra Capital Ltd., to ensure timely and accurate dividend credit.

Dhanuka Agritech Ltd has informed shareholders about the availability of its Integrated Annual Report for FY 2025-26. In compliance with SEBI Listing Regulations, the company is sending a letter with a QR code and weblink to shareholders whose email addresses are not registered. The report and AGM notice are accessible via the company website (www.dhanuka.com), NSDL (www.evoting.nsdl.com), and stock exchange websites. The 41st AGM is scheduled for August 3, 2026, via VC/OAVM. Key dates include July 17 for the record date for final dividend, and July 27 for TDS exemption forms and e-voting cut-off.

Dhanuka Agritech Limited has submitted its Business Responsibility and Sustainability Report (BRSR) for the Financial Year 2025-26. The report, prepared on a standalone basis, details the company's corporate identity, registered and corporate addresses, and contact information for queries. It outlines business activities contributing to 90% of turnover, with manufacturing of chemicals accounting for 88.14% and wholesale trading for 11.86%. Agrochemicals represent 100% of products sold. The company operates across 56 locations nationally and serves international markets including Bangladesh, Nepal, UAE, and Argentina, with exports contributing 1.15% to turnover. The report also provides employee and worker statistics, categorizing them based on remuneration thresholds defined by the New Labour Code.